CHEM E-120 Harvard University Extension School 1 Pain SAR of Opioids April 13, 2011.

53
CHEM E-120 Harvard University Extension School 1 Pain SAR of Opioids April 13, 2011
  • date post

    19-Dec-2015
  • Category

    Documents

  • view

    236
  • download

    1

Transcript of CHEM E-120 Harvard University Extension School 1 Pain SAR of Opioids April 13, 2011.

Page 1: CHEM E-120 Harvard University Extension School 1 Pain SAR of Opioids April 13, 2011.

CHEM E-120Harvard University Extension School

1

PainSAR of OpioidsApril 13, 2011

Page 2: CHEM E-120 Harvard University Extension School 1 Pain SAR of Opioids April 13, 2011.

Pain

Nociceptive Pain

due to a stimulus (hammer, campfire) activation of high threshold sensory pathwaysacting via neurons called nociceptors

Clinical Pain

Inflammatoryvariety of chemical mediators stimulate nociceptors e.g. cytokines (IL-1 and TNF-α)

Neuropathicinitiated or caused by a lesion or dysfunction of the sensory nervous systemFibromyalgiachronic, widespread pain, fatigue, and heightened pain in response to pressure (allodynia)

2

Page 3: CHEM E-120 Harvard University Extension School 1 Pain SAR of Opioids April 13, 2011.

Neuronal Pain Pathway

Dorsal Horn

3

Drug Targets/Mediators

Ascending PathwayNMDA/glutamateSubstance P/NK-1Nitric oxide

Descending PathwaySerotoninGABANorepinephrineOpioids

Peripheral TissueNSAIDSProstaglandinsHistamines

sensation of pain

amygdala, NAccdysphoriaunpleasant aspectsof pain

flexor response

Page 4: CHEM E-120 Harvard University Extension School 1 Pain SAR of Opioids April 13, 2011.

Nerve Fibers and Nociceptors

Nerve fiber types organized for size (axonal diameter) of 1 - 4. 1 -3 are myelinated and Group 4 are demyelinated. Also classified as A, B, or C where C is demyelinated.

Larger diameter fibers conduct signal faster that smaller diameter fibers.

Group 3 – nocicpetion (sharp pain), cold receptors, 5 – 30 m/secGroup 4 – nociception (dull pain), warmth, itch, 0.5 – 2 m/sec

Transient Receptor Potential (TRP) – nonselective tetrameric ion channels that respond to heat and cold. TRPV1-4, TRPM8, TRPA1

TRPV1 - Threshold of > 430C (capsaicin, H+, anandamide)TRpM8 – Threshold of < 250C (menthol)

Mechanical nociceptors

4

Page 5: CHEM E-120 Harvard University Extension School 1 Pain SAR of Opioids April 13, 2011.

Role of Ion Channels in Pain

5

Action potential from site of stimulus to cortex mediated by Na+, K+, and Ca2+

voltage-gated ion channels.

Na+ mediates action potential

Opening of Na+ channels propagates action potential by depolarization of neuron Nav 1.3 is a potential target, is upregulated following injury.

K+ mediates membrane potential

Opening of channel allows K+ flow out polarizing the neuron. GIRK – G-protein-coupled, inward rectifying potassium channel. Activated by opioids, cannabinoids, and α-2 adrenergic agonists

Ca2+ mediates neurotransmitter releasePresynaptic activation releases neuropeptides (substance P) and glutamateCav 2.2 inhibitor - Ziconotide

Page 6: CHEM E-120 Harvard University Extension School 1 Pain SAR of Opioids April 13, 2011.

Pain Receptors – Dorsal Horn

6

Glu mediates fast transmission

G-protein-coupled, inward rectifying potassium channel

Page 7: CHEM E-120 Harvard University Extension School 1 Pain SAR of Opioids April 13, 2011.

Dorsal Horn Neuronal Networks – Sites for Analgesics

7

sites of action to control pain

Page 8: CHEM E-120 Harvard University Extension School 1 Pain SAR of Opioids April 13, 2011.

Sensitization

8

Normal nociceptive pain perception follows well regulated pathways and ceases onremoval of noxious stimulus.

Neuropathic pain is characterized by exaggerated pain that continues in the absence of a noxious stimulus.

Peripheral Sensitization

Increased sensitivity ofNociceptors to stimulus

Conformational changes in GPCR2nd messenger system activationactivation of arachidonic acid cascade

Central Sensitization

Increased activation of dorsal hornneurons and transcriptional changesUpregulation of transcription factorsIncrease COX and NOS synthesis

Windup phenomenon

Repeated stimulation of C fibersResponse to stimulus increases postsynaptic NMDA and NK1 activation (medication- block NMDA receptors)

Page 9: CHEM E-120 Harvard University Extension School 1 Pain SAR of Opioids April 13, 2011.

Sensitization

9

transcriptional changes

Page 10: CHEM E-120 Harvard University Extension School 1 Pain SAR of Opioids April 13, 2011.

10

Sensitization of Peripheral Nociceptors

Kandel Chapter 24

Page 11: CHEM E-120 Harvard University Extension School 1 Pain SAR of Opioids April 13, 2011.

General Anesthetics

11

State of drug-induced absence of perception of all sensations: inculdes unconciousness, analgesia, amnesia, and muscle relaxation.

General anesthesia is usually induced with intravenous anesthetics, and maintained with inhalation anesthetics

First demonstrated at MGH in 1846 – diethyl ether

Inhalation anesthetics:• Very diverse drugs: ether, nitrous oxide, halothane• Mechanism of action largely unknown (probably inhibition of glutamate receptors and

increased activity of GABA receptors)• Actions are affected by cardiac output and ventilation rate• Elimination predominantly through exhalation of the unchanged gas

Page 12: CHEM E-120 Harvard University Extension School 1 Pain SAR of Opioids April 13, 2011.

General Anesthetics

12

Intravenous anesthetics:• Thiopental

Barbiturate with very high lipid solubility, rapid action, but accumulates in fat with extended use, narrow therapeutic range, no analgesic effect

• PropofolRapidly metabolized => quick recovery, drug of choice for out-patient surgeryUsed as continuous infusion

• KetaminePhencyclidine analogue, good analgesia and amnesia, High incidence of hallucinations during recovery.

• Midazolame (Benzodiazepine)

OH

Propofol

OH

BHTpreservative

N

PhencyclidenePCP, angel dust

NH

O

Cl

Ketamine

PCP mimics both negative and positive symptoms of schizophreniaNMDA (glutamate) antagonist. Binds to open ion channel, blocks glutamate transmission

Page 13: CHEM E-120 Harvard University Extension School 1 Pain SAR of Opioids April 13, 2011.

General Anesthetics

13

Potency and speed of induction/recovery depend on two properties of the anesthetic:

• Solubility in blood (blood:gas partition coefficient) Speed of onset is inversely correlated with the solubility in blood (more soluble =>

slower onset): blood acts as a reservoir that “needs to be filled”• Solubility in lipid (oil:gas partition coefficient)

Determines the potency of the anesthetic More lipophilic anesthetics have higher potencyLipophilic anesthetics gradually accumulate in body fat (> prolonged “hang-over”)

Modern anesthesia:Employs a combination of drugs to achieve the goals of a “balanced anesthesia”:

– Anxiolytic premedication (Diazepines)– Autonomic stabilization (Atropin: prevents visceral reflexes)– Analgetics (Opioids: Fentanyl)– Muscle relaxant (Pancuronium)

Page 14: CHEM E-120 Harvard University Extension School 1 Pain SAR of Opioids April 13, 2011.

14

Penetrate membrane in unionized (neutral) form

pKa clogP % base at pH 7.4 onset (minutes)

Lidocaine 7.9 1.95 25% 2 – 4

Procaine 9.1 2.5 2% 14 - 18

Bind to Na+ channel in theionized form

General Anesthetics

Page 15: CHEM E-120 Harvard University Extension School 1 Pain SAR of Opioids April 13, 2011.

Local Anesthetics/Analgesics

15

Cocaine First local anesthetic, Isolated in 1860 from Coca (Indians, who chewed Coca leaves for their

psychotropic effects, knew about the numbing effect they produced on the mouth and tongue)

Procaine (First synthetic local anesthetic)

Non-Steroidal Anti-Inflammatory Drugs (NSAIDs):

Act by inhibiting CycloOXygenases (COX) => no PG production (PG sensitize nocireceptors)COX-1: Constitutively expressed => house-keeping functionCOX-2: Induced by pro-inflammatory factors (TNFα, IL-1)COX-3: Just recently discovered

Classical NSAIDs: inhibit both COX-1 and COX-2 (inhibition is reversible,with the exception of Aspirin) => housekeeping PGs reduced => side effects (gastrointestinal, bronchospasms,…)

2nd generation NSAIDs:

COX-2 specific => only the inflammatory response is inhibited => fewer side effects

Page 16: CHEM E-120 Harvard University Extension School 1 Pain SAR of Opioids April 13, 2011.

Analgesics

16

COX-2 specific NSAIDs:

• Rofecoxib (Vioxx®)Launched in 1999Marketed in 86 countries: 2.5 bill.$ /yearRecent trial to test Rofecoxib for efficacy in colorectal polyps treatment revealed

an increased risk of heart disease (+ 50%) after 18 month continuous use

Sept. 2004: Merck voluntarily withdrew Vioxx® from the market

• Celecoxib (Celebrex®) April 2005: FDA required Pfizer to include a “boxed warning” indicating apotential risk of cardiovascular side effects

• Valdecoxib (Bextra®)April 2005: FDA required Pfizer to withdraw Bextra® from the market due tounfavorable risk vs. benefit profile (mostly already known adverse skin reactions)

Page 17: CHEM E-120 Harvard University Extension School 1 Pain SAR of Opioids April 13, 2011.

Opioid Analgesics

17

For moderate to severe pain the drugs of choice are based on the opioid analgesics acting as agonists on opioid receptors.

Alkaloids derives from Papaver somniferum– Already used 4000 B.C. (opius greek: “little juice”)– 1805: Morphine isolated (morpheus: Greek god of dreams)– 1874: synthesis of heroin (introduced in 1898 by Bayer as a cough medicine)– Opium tincture heavily used during civil war– Opiates freely available in the US until 1914 (Harrison Act)

MorphineCodeine: 3-methoxy-morphine (CYP2D6 inhibitors (e.g. Fluoxetine) reduce efficacy)Hydrocodone (Vicodin®):– Often combined with NSAIDs– Contained in over 200 preparations in the USOxycodone (OxyContin®)Meperidine (Pethidine): much shorter duration than morphine, used during labourFentanylEtorphine: 1000x more potent than morphine

Page 18: CHEM E-120 Harvard University Extension School 1 Pain SAR of Opioids April 13, 2011.

Opioid Analgesics

1. Naturally occurring opioids 2. Synthetic analgesics based on morphine

3. Synthetic Analgesics

MorphineButorphanol

Fentanyl

18

Page 19: CHEM E-120 Harvard University Extension School 1 Pain SAR of Opioids April 13, 2011.

Opioid Receptors

19

Membrane bound G-protein coupled receptors: Mu, Delta, Kappa

Opioid receptors have generally high homology73 – 76% in TM domains34 - 40% in extracellular domains63 – 66 % in intracellular domains

Mu receptor - 400 amino acids

Endogenous peptidic ligands for opioid receptors, proopioid proteins synthesized in nucleus and transported to synapse via microtubules where they are processed by peptidases

Mu endomorphine-1 (Tyr-Pro-Trp-Phe-NH2) endomorphine-2 (Tyr-Pro-Phe-Phe-NH2) β-endorphin (31 AA)

Delta enkephalins (5 – 8 AA)

Kappa dynorphins (8 – 17 AA)

NH2-Try-Gly-Gly-Phe-

Page 20: CHEM E-120 Harvard University Extension School 1 Pain SAR of Opioids April 13, 2011.

Opioid Receptor Topology

20

% homology (identical amino acids) between the 3 opioid receptors

N-terminus

C-terminus

Extracellular loops 1-3recognition point for endogenous peptides

Intracellular loops 1-3

TM 3,6,7 form binding pocket

Page 21: CHEM E-120 Harvard University Extension School 1 Pain SAR of Opioids April 13, 2011.

Opioid Mechanism of Action

21

Local enkephalin-containing interneurons (ENK) exert both presynaptic and postsynaptic inhibitory actions at the synapses. Opioids decrease Ca2+ influx and increase Serotonergic and noradrenergic neurons in the brain stem activate the local opioid interneurons and also suppress the activity of spinothalamic projection neurons.

NE/5-HT brain

ENKENK

stimulus

To brain

Release of peptidic opioidsopioid receptors pre/post synaptic

Antidepressants as AnalgesicsCNS Drugs 2008,22, 139-156

Page 22: CHEM E-120 Harvard University Extension School 1 Pain SAR of Opioids April 13, 2011.

Binding Affinity and Efficacy

22

Binding affinity

CHO cells mu ([3H]-DAMGO), delta ([3H]-naltrindole or DPDPE), kappa ([3H]-U69593HEK-293 cells

Mouse vas deferens mu, delta, kappaGuinea-pig myenteric plexus-longitudinal muscle mu and kappaRabbit vas deferens kappaHamster vas deferens delta

Functional assays

[35S]GTPγS in CHO, HEK-293 cell membrane preparations

Page 23: CHEM E-120 Harvard University Extension School 1 Pain SAR of Opioids April 13, 2011.

Animal Models of Analgesic Activity

23

Hot-Plate Test – Acute Pain

Animals are injected with test compounds or vehicle (controls) and then placed on the hot plate (550C) one at a time. Latency to respond to the heat stimulus is measured by the amount of time it takes for the animal to lick one of its paws.

Tail-Flick Test – Acute Pain

high-intensity thermal stimulus is directed to the tail of a mouse or a rat. The time from onset of stimulation to a rapid flick/withdrawal of the tail from heat source is recorded.

Formalin Test

states of persistent pain in which tissue damage occurs

Current Protocols in Neuroscience (1999) 8.9.1-8.9.15

Page 24: CHEM E-120 Harvard University Extension School 1 Pain SAR of Opioids April 13, 2011.

Analgesic Activity

24

Page 25: CHEM E-120 Harvard University Extension School 1 Pain SAR of Opioids April 13, 2011.

Opioid Analgesic Dosing

25

Neurobiology of Addiction p124

Page 26: CHEM E-120 Harvard University Extension School 1 Pain SAR of Opioids April 13, 2011.

Binding Model of Morphine

26

Asp147 of TM3

His297 of TM6

at pH = 7 1 10

Page 27: CHEM E-120 Harvard University Extension School 1 Pain SAR of Opioids April 13, 2011.

Morphine SAR Results

27

morphine MOR Ki = 1 nMcodeine MOR Ki = 135 nM

An Introduction to Medicinal ChemistryG. Patrick, 2005, Chapter 21

Page 28: CHEM E-120 Harvard University Extension School 1 Pain SAR of Opioids April 13, 2011.

Morphine SAR Results

28

Page 29: CHEM E-120 Harvard University Extension School 1 Pain SAR of Opioids April 13, 2011.

Morphine SAR Results

29

μ/δ/κ (nM)

1.7/85/16

1.1/140/47

charged N+ does not cross BBB but – full analgesic activity icv

Page 30: CHEM E-120 Harvard University Extension School 1 Pain SAR of Opioids April 13, 2011.

Morphine SAR Results

30

Page 31: CHEM E-120 Harvard University Extension School 1 Pain SAR of Opioids April 13, 2011.

Morphine SAR – N Group

31

Page 32: CHEM E-120 Harvard University Extension School 1 Pain SAR of Opioids April 13, 2011.

Morphine SAR Results – Analgesic Activity

32

Removal of OH reduces activityMethylation reduces activityAcetylation reduces activity

Removal increasesactivity

Removal of OH increases activityOH to ketone reduces activityOH to ketone + reduction of 7,8double bond INC activityAcetylation INC activity

Reduction INC activity

H to OH INC activity

Page 33: CHEM E-120 Harvard University Extension School 1 Pain SAR of Opioids April 13, 2011.

Structural Changes

33

Page 34: CHEM E-120 Harvard University Extension School 1 Pain SAR of Opioids April 13, 2011.

Structural Changes

34

Complete loss of activity

Page 35: CHEM E-120 Harvard University Extension School 1 Pain SAR of Opioids April 13, 2011.

Structural Changes – Benzomorphans (-C&D)

35

Page 36: CHEM E-120 Harvard University Extension School 1 Pain SAR of Opioids April 13, 2011.

Structural Changes - Removal Rings B, C, &D

36

Page 37: CHEM E-120 Harvard University Extension School 1 Pain SAR of Opioids April 13, 2011.

Remifentanil: Short-acting analgesic

37

N

N

O

Fentanyl

80 X morphine

N

O

O

O

OO

Remifentanil

N

O

O

S

Sufentanil

600 - 800 X morphine

N

O

O

O

OHO

1000 x lesspotent in GPL

350 X les potent in FTW

N

O

O

O

OO

blood

Page 38: CHEM E-120 Harvard University Extension School 1 Pain SAR of Opioids April 13, 2011.

38

JMC 1991, 34, 2202

Page 39: CHEM E-120 Harvard University Extension School 1 Pain SAR of Opioids April 13, 2011.

Structural Changes - Removal Rings B, C, D, & E

39

Methadone greater oral potency and longer duration of activity than many other opioids20 mg/8-12 hours. t1/2 ~ 19 hours at pH 5.2, at pH 7.8 t1/2 ~ 42 hours

Propoxyphene (Darvon)Oral dosage ~ 1/12 potency of morphineAnalgesic effect ~ same as aspirin

Page 40: CHEM E-120 Harvard University Extension School 1 Pain SAR of Opioids April 13, 2011.

Oripavines

40

Etorphine

10,000 X morphineCrosses BBB 300 X morphine20 X mu affinity

Page 41: CHEM E-120 Harvard University Extension School 1 Pain SAR of Opioids April 13, 2011.

Oripavines

41

No analgesic activity

Page 42: CHEM E-120 Harvard University Extension School 1 Pain SAR of Opioids April 13, 2011.

Buprenorphine

42

R Tail-flick (agonist) antagonism

Me 0.005 317

Et 6.8 68

Pr 213 0.17

t-Bu 19 4

Bu 53 0.56

Morphine 1 <0.01

Nalorphine 0.30 1

Mu partial agonistDelta antagonistKappa partial agonist

Analgesic effect w/o toleranceand less respiratory depressionNon-oral (sublingual, transdermal)Suboxone, Subutex®

Page 43: CHEM E-120 Harvard University Extension School 1 Pain SAR of Opioids April 13, 2011.

Agonist vs Antagonist

43

Page 44: CHEM E-120 Harvard University Extension School 1 Pain SAR of Opioids April 13, 2011.

Agonist vs Antagonist

44

Overlaps with morphineAgonist activity

antagonistaxial hydroxyphenylbut N-substituentimportant

Page 45: CHEM E-120 Harvard University Extension School 1 Pain SAR of Opioids April 13, 2011.

Agonist vs Antagonist

45

Morphine (gray)

axial 3-methyl restoresantagonist activity

Page 46: CHEM E-120 Harvard University Extension School 1 Pain SAR of Opioids April 13, 2011.

Agonist vs Antagonist

46

Anionic site

Phenolic site

N-substituent site

Page 47: CHEM E-120 Harvard University Extension School 1 Pain SAR of Opioids April 13, 2011.

Receptor Modeling

47

3D xray rhodopsin (Protein Data Bank)

Alignment of conserved mu amino acid sequences with rhodopsin

ModellerHomology Model

Protonated ligands Stable conformation

Docked by ASP (3.32) + NH+

Interaction and HB phenol &HIS H6.52

Simulatd annealing

The Open Structural Biology Journal, 2008, 2, 8-20

The Modeller, Clustal W, SeqFold and Profile-3D (Verify-3D method) programs were used within the InsightII software platform (Accelrys Inc., v.2000.1).

Page 48: CHEM E-120 Harvard University Extension School 1 Pain SAR of Opioids April 13, 2011.

Agonist vs AntagonistMorphine

48

The Open Structural Biology Journal, 2008, 2, 8-20

Page 49: CHEM E-120 Harvard University Extension School 1 Pain SAR of Opioids April 13, 2011.

Agonist vs Antagonist

49

Page 50: CHEM E-120 Harvard University Extension School 1 Pain SAR of Opioids April 13, 2011.

50

A fragment of MD simulation showing breaking of D3.32-Y7.43 hydrogen bond (3-7 lock) in the complex morphine – MOR. Morphine phenolic hydroxyl group binds to H6.52. Carbon atoms of morphine are colored in orange. Numbers (in Å) inform about selected distances (showed as dashed lines).

Page 51: CHEM E-120 Harvard University Extension School 1 Pain SAR of Opioids April 13, 2011.

51

A whole MD simulation of antagonist complex NTX – MOR. NTX phenolic hydroxyl group is restrained to form a hydrogen bond with H6.52. The simulation shows breaking of D3.32-Y7.43 connection (3-7 lock), break of (TRP) W6.48 – (Ser) S7.46 hydrogen bond and a rotamer swap of W6.48. Numbers (in Å) inform about selected distances (showed as dashed lines).

Page 52: CHEM E-120 Harvard University Extension School 1 Pain SAR of Opioids April 13, 2011.

Morphine Pharmacokinetics

O

N

HOOH

H

O

N

O OH

H

O

N

HOO

H

O

HOHO

HO

HO

O

OHOH

OH

OH

Phase 2

Glucuronidation

Morphine-3-glucuronide

Morphine-6-glucuronide

Bioavaliability (humans) 24% PO; 100% IM, 100% IV; 60% transnasalRapid tissue distribution~ 70% subjected to Phase 2 metabolism

M3G:morphine 6:1 M6G:morphine 1:1does not bind to MOR psychoactive

Morphine (not glucuronides) transported across BBB by P-glycoprotein (P-gp)

Medicinal Research Reviews, 2005, 25, 521

Page 53: CHEM E-120 Harvard University Extension School 1 Pain SAR of Opioids April 13, 2011.

53

Heroin Hydrolysis

Heroin does not bind to opioid receptorsIn vivo t1/2 in blood of heroin: 4 - 5 minutes

6-AM: 30 minutes

Step 1 - human serum cholinesterase (EC 3.1.1.8) & arylesterase (EC. 3.1.1.2)

Human liver carboxyesterase 1

Heroin to 6-acetylmorphine kcat/Km = 314 mM-1min-1

6-acetylmorphine to morphine kcat/Km = 22 mM-1min-1